Studies

CellWell record HH-433063

EP1635 - ECE_3137 - Metabolic dysfunction -- associated steatotic liver disease as the initial presentation of subclinical hypothyroidism

Marin Pecani; Paola Andreozzi

European Journal of Endocrinology ยท 2026

In plain language

In a 35-year-old man with fatty liver disease and autoimmune subclinical hypothyroidism, levothyroxine plus diet and exercise was followed by normal liver enzymes, a 6 kg weight loss, and TSH falling to 2.4.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on DOI

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-433063

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.